As of August 2026, 29 paid clinical trials are recruiting in Lisle, Illinois. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Lisle offers studies at sites including Rush MD Anderson Cancer Center at Rush Lisle for conditions such as Amblyopia, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Aortic Valve Stenosis. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Lisle, IL at 11 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Rush MD Anderson Cancer Center at Rush Lisle | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer | 8 |
| Accellacare of Duly | Neoplasm Metastasis, Breast Neoplasms, Carcinoma, Transitional Cell | 7 |
| Duly Health and Care | Advanced Breast Cancer, FGFR Gene Alterations, FGFR Gene Amplification | 3 |
| Progressive Eye Care | Amblyopia | 3 |
| Duly Health | Benign Prostatic Hyperplasia, Metastatic Castration-resistant Prostate Cancer | 2 |
| NextStage Clinical Research | Intermediate Risk Non-Muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ | 2 |
| Alexian Brothers Hospital | Aortic Stenosis, Calcific, Aortic Valve Stenosis | 1 |
| Alexian Brothers Hospital Network | Aortic Valve Insufficiency, Aortic Valve Stenosis | 1 |
| Duly Health and Care (Bone Scintigraphy) | Metastatic Castration-Resistant Prostate Cancer | 1 |
| Duly Health and Care - Lisle | Non-small Cell Lung Cancer | 1 |
| Duly Health and Care Chicago | Low Grade Upper Tract Urothelial Carcinoma | 1 |
Recruiting trials in Lisle grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 29 recruiting clinical trials in Lisle, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Lisle compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Lisle include Amblyopia (3), Anatomic Stage I Breast Cancer AJCC v8 (2), Anatomic Stage II Breast Cancer AJCC v8 (2), Aortic Valve Stenosis (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lisle on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Lisle include Rush MD Anderson Cancer Center at Rush Lisle, Accellacare of Duly, Duly Health and Care, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Lisle are Cancer & tumors (19), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.